Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas B Stanley

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Antiviral Research|June 14, 2002
Small molecule modulators of HIV Rev/Rev response element interaction identified by random screeningRichard L Chapman, Thomas B Stanley, Richard Hazen, et al.
The Journal of Biological Chemistry|June 27, 2007
Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosteroneEmily B Askew, Robert T Gampe, Thomas B Stanley, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
VitriFlex: An Open-Source, Modular, and Customizable Robotic Platform for Cryo-EM Grid PreparationWyatt Peele, Kedar Sharma, Thomas B Stanley, et al.
Molecular Endocrinology (Baltimore, Md.)|June 28, 2007
The nuclear receptor-coactivator interaction surface as a target for peptide antagonists of the peroxisome proliferator-activated receptorsNiharika B Mettu, Thomas B Stanley, Mary A Dwyer, et al.
The Biochemical Journal|May 4, 2002
Characteristics and composition of the vitamin K-dependent gamma-glutamyl carboxylase-binding domain on osteocalcinRoger J T J Houben, Dirk T S Rijkers, Thomas B Stanley, et al.
Molecular Cell|November 5, 2004
Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominanceBin He, Robert T Gampe, Adam J Kole, et al.
Biochemistry|August 6, 2003
Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinityThomas B Stanley, Lisa M Leesnitzer, Valerie G Montana, et al.
Molecular Endocrinology (Baltimore, Md.)|November 3, 2007
Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonistBarry G Shearer, David J Steger, James M Way, et al.
The Journal of Biological Chemistry|June 22, 2005
A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptorRandy K Bledsoe, Kevin P Madauss, Jason A Holt, et al.
Molecular Endocrinology (Baltimore, Md.)|March 16, 2007
A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulatorKevin P Madauss, Eugene T Grygielko, Su-Jun Deng, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Antiviral Research|June 14, 2002
Small molecule modulators of HIV Rev/Rev response element interaction identified by random screeningRichard L Chapman, Thomas B Stanley, Richard Hazen, et al.
The Journal of Biological Chemistry|June 27, 2007
Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosteroneEmily B Askew, Robert T Gampe, Thomas B Stanley, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
VitriFlex: An Open-Source, Modular, and Customizable Robotic Platform for Cryo-EM Grid PreparationWyatt Peele, Kedar Sharma, Thomas B Stanley, et al.
Molecular Endocrinology (Baltimore, Md.)|June 28, 2007
The nuclear receptor-coactivator interaction surface as a target for peptide antagonists of the peroxisome proliferator-activated receptorsNiharika B Mettu, Thomas B Stanley, Mary A Dwyer, et al.
The Biochemical Journal|May 4, 2002
Characteristics and composition of the vitamin K-dependent gamma-glutamyl carboxylase-binding domain on osteocalcinRoger J T J Houben, Dirk T S Rijkers, Thomas B Stanley, et al.
Molecular Cell|November 5, 2004
Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominanceBin He, Robert T Gampe, Adam J Kole, et al.
Biochemistry|August 6, 2003
Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinityThomas B Stanley, Lisa M Leesnitzer, Valerie G Montana, et al.
Molecular Endocrinology (Baltimore, Md.)|November 3, 2007
Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonistBarry G Shearer, David J Steger, James M Way, et al.
The Journal of Biological Chemistry|June 22, 2005
A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptorRandy K Bledsoe, Kevin P Madauss, Jason A Holt, et al.
Molecular Endocrinology (Baltimore, Md.)|March 16, 2007
A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulatorKevin P Madauss, Eugene T Grygielko, Su-Jun Deng, et al.
Pageof 2